General Info

EpiCept Corporation is a specialty pharmaceutical company focused on the development and commercialization of topically delivered prescription pain management therapeutics. The company attempts to address medical needs for the treatment of moderate and severe pain where existing treatments are ineffective or cause significant, adverse side effects. The company is developing pain products for diverse clinical uses, including peripheral neuropathies, surgical pain, migraine headache and oral-mucositis pain. It has established alliances with the biotechnology product company Adolor Corporation, which has licensed the company s LidoPAIN SP product for the treatment of pain associated with surgical incisions. It has also entered into a licensing agreement with Endo Pharmaceuticals pertaining to the exclusive worldwide right to commercialize LidoPAIN BP. The Company is headquartered in Tarrytown, N.Y., and has a subsidiary company located in Munich, Germany.